跳至主要内容
临床试验/NCT01442883
NCT01442883已完成不适用

Understanding the Mechanisms of Progressive Decrease in Blood Pressure After Renal Nerve Ablation

University of Erlangen-Nürnberg Medical School2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27
试验地点
2
主要终点
Albuminuria

研究概览

简要总结

In patients with treatment resistent hypertension renal nerve ablation emerged as an effective interventional approach of treating hypertensive disease with a progressively increasing fall in blood pressure. Decreased activity of the sympathetic nervous system is one of the major underlying pathogenetic mechanism of the fall in blood pressure but the precise mechanisms that causes the fall in blood pressure in the short-term and, in particular, long-term remains elusive. The objective of the study is to understand the pathogenetic mechanisms of renal denervation beyond the reduced activity of the sympathetic nervous system. In 100 hypertensive patients most advanced technology will be applied, before and repeatedly after renal denervation, throughout the follow-up period of 1 year. Systemic activity of the renin angiotensin aldosterone system, renal perfusion (by MRI spin labelling technique), local activity of the renin angiotensin system in the kidney (urinary angiotensinogen concentrations), sodium excretion and total sodium content (23 Na-MRI technique) and vascular remodelling of small (retinal arterioles 50 - 150 µm) and large arteries (carotid - femoral pulse wave velocity and augmentation index, both measured over 24 hours) will be assessed. Identification of the pathogenetic mechanisms involved in the fall in blood pressure after renal denervation may help to identify those hypertensive patients that profit most from renal nerve ablation in terms of blood pressure reduction.

The investigators propose the following hypotheses why a progressive decrease in blood pressure happens, in addition to the decreased activity of the central nervous system, after renal nerve ablation:

Short term effects:

A)Preservation of renal function and perfusion B)Reduction of local RAS activity in the kidney C)Exaggerated sodium excretion immediately after renal nerve ablation

Long term effects:

D)Decrease of total sodium content after 6 and 12 months. E)Improvement of vascular wall properties after 6 and 12 months

详细描述

In patients with treatment resistent hypertension renal nerve ablation emerged as an effective interventional approach of treating hypertensive disease with a progressively increasing fall in blood pressure. Decreased activity of the sympathetic nervous system is one of the major underlying pathogenetic mechanism of the fall in blood pressure but the precise mechanisms that causes the fall in blood pressure in the short-term and, in particular, long-term remains elusive. The objective of the study is to understand the pathogenetic mechanisms of renal denervation beyond the reduced activity of the sympathetic nervous system. In 100 hypertensive patients most advanced technology will be applied, before and repeatedly after renal denervation, throughout the follow-up period of 1 year. Systemic activity of the renin angiotensin aldosterone system, renal perfusion (by MRI spin labelling technique), local activity of the renin angiotensin system in the kidney (urinary angiotensinogen concentrations), sodium excretion and total sodium content (23 Na-MRI technique) and vascular remodelling of small (retinal arterioles 50 - 150 µm) and large arteries (carotid - femoral pulse wave velocity and augmentation index, both measured over 24 hours) will be assessed. Identification of the pathogenetic mechanisms involved in the fall in blood pressure after renal denervation may help to identify those hypertensive patients that profit most from renal nerve ablation in terms of blood pressure reduction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • treatment resistant hypertension
  • chronic kidney disease 3 - 5
  • male of female aged over 18 years
  • written informed consent
  • agreement to attend all study visits as planned in the protocol

排除标准

  • any contraindications for MRI
  • claustrophobia
  • strabismus
  • severe ocular diseases
  • history of epilepsia

结局指标

主要结局

Albuminuria

时间窗: baseline, 6 months

Change in urinary albumin/creatinine ratio from baseline to 6 months post renal nerve ablation (spot urine)

office BP

时间窗: baseline, 6 months

Change in office blood pressure from baseline to 6 months post-renal nerve ablation

24-h ABPM

时间窗: baseline, 6 months

Change in 24 hour ambulatory blood pressure (ABPM) from baseline to 6 months post-renal nerve ablation

Magnetic resonance imaging (MRI)

时间窗: baseline, 6 months

* change in total sodium content measured by MRI from baseline to 6 months post-renal nerve ablation * change in renal perfusion measured by MRI spin labelling technique from baseline to 6 months post-renal nerve ablation

local RAS activity

时间窗: baseline, 6 months

Change in urinary angiotensinogen concentration from the morning spot urine from baseline to 6 months post-renal nerve ablation

systemic RAS activity

时间窗: baseline, 6 months

* change in sodium, potassium and creatinine from baseline to 6 months post-renal nerve ablation * change in aldosterone excretion from baseline to 6 months post-renal nerve ablation * change in sodium / potassium ratio from baseline to 6 months post-renal nerve ablation * change in plasma renin activity and angiotensin II concentration at least 30 minutes of rest in a supine position and immediately after standing from baseline to 6 months post-renal nerve ablation

vascular structure and function of large and small arteries

时间窗: baseline, 6 months

* change in flow-mediated vasodilation (FMD) from baseline to 6 months post-renal nerve ablation * change in scanning laser Doppler flowmetry (SLDF) from baseline to 6 months post-renal nerve ablation * change in pulse wave analysis (PWA) from baseline to 6 months post-renal nerve ablation * change in pulse wave velocity from (PWV) baseline to 6 months post-renal nerve ablation * change in urinary albumine creatinine ratio (UACR) of the morning spot urine sample from baseline to 6 months post-renal nerve ablation

次要结局

  • BP(1 and 12 months)
  • MRI(1 day, 1 and 12 months)
  • systemic RAS activity(1 day and 1 months)
  • vascular structure and function of large and small arteries(12 months)
  • local RAS activity(1 day and 1 months)

研究者

发起方
University of Erlangen-Nürnberg Medical School
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Renal Nerve Ablation in Chronic Kidney Disease... | 临床试验